SARS-CoV-2 Surveillance in Belgian Wastewaters.

SARS-CoV-2 alerting indicator correlation public health authority surveillance viral load per capita viral to faecal ratio wastewater-based epidemiology

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
02 09 2022
Historique:
received: 07 07 2022
revised: 30 08 2022
accepted: 30 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Wastewater-based surveillance was conducted by the national public health authority to monitor SARS-CoV-2 circulation in the Belgian population. Over 5 million inhabitants representing 45% of the Belgian population were monitored throughout 42 wastewater treatment plants for 15 months comprising three major virus waves. During the entire period, a high correlation was observed between the daily new COVID-19 cases and the SARS-CoV-2 concentration in wastewater corrected for rain impact and covered population size. Three alerting indicators were included in the weekly epidemiological assessment: High Circulation, Fast Increase, and Increasing Trend. These indicators were computed on normalized concentrations per individual treatment plant to allow for a comparison with a reference period as well as between analyses performed by distinct laboratories. When the indicators were not corrected for rain impact, rainy events caused an underestimation of the indicators. Despite this negative impact, the indicators permitted us to effectively monitor the evolution of the fourth virus wave and were considered complementary and valuable information to conventional epidemiological indicators in the weekly wastewater reports communicated to the National Risk Assessment Group.

Identifiants

pubmed: 36146757
pii: v14091950
doi: 10.3390/v14091950
pmc: PMC9506219
pii:
doi:

Substances chimiques

RNA, Viral 0
Waste Water 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

mSystems. 2021 Mar 2;6(2):
pubmed: 33653938
Environ Sci Technol. 2021 Mar 16;55(6):3514-3519
pubmed: 33656856
Arch Public Health. 2021 Oct 27;79(1):188
pubmed: 34706768
Sci Total Environ. 2021 May 26;789:148047
pubmed: 34323839
Sci Total Environ. 2020 Aug 15;730:138875
pubmed: 32371231
Water Sci Technol. 2021 Oct;84(8):1997-2013
pubmed: 34695026
JAMA. 2020 Jun 9;323(22):2249-2251
pubmed: 32374370
Sci Total Environ. 2020 Aug 1;728:138764
pubmed: 32387778
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34369565
Water Res. 2021 Jan 1;188:116560
pubmed: 33137526
Water Res X. 2021 May 1;11:100100
pubmed: 33842875
Sci Total Environ. 2022 May 10;820:153290
pubmed: 35066048
PLoS Biol. 2006 Jan;4(1):e3
pubmed: 16336043
Curr Pollut Rep. 2021;7(2):160-166
pubmed: 33842197
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Methods Protoc. 2020 Aug 18;3(3):
pubmed: 32824827
Sci Total Environ. 2021 Jan 10;751:141750
pubmed: 32861187
Sci Total Environ. 2021 May 20;770:145319
pubmed: 33508669
Sci Total Environ. 2021 Sep 10;786:147398
pubmed: 33971598
Sci Total Environ. 2021 May 26;789:148043
pubmed: 34323818
Water Res. 2021 Feb 1;189:116620
pubmed: 33212338
Chem Eng J. 2021 Jul 1;415:129039
pubmed: 33642938
Environ Res. 2021 Sep;200:111374
pubmed: 34058182
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
Water Res X. 2021 Jan 1;10:100086
pubmed: 33398255
Sci Total Environ. 2022 Jan 20;805:150121
pubmed: 34534872

Auteurs

Raphael Janssens (R)

Epidemiology of Infectious Diseases, Sciensano, 1050 Brussels, Belgium.

Sven Hanoteaux (S)

Epidemiology of Infectious Diseases, Sciensano, 1050 Brussels, Belgium.

Hadrien Maloux (H)

Epidemiology of Infectious Diseases, Sciensano, 1050 Brussels, Belgium.

Sofieke Klamer (S)

Epidemiology of Infectious Diseases, Sciensano, 1050 Brussels, Belgium.

Valeska Laisnez (V)

Epidemiology of Infectious Diseases, Sciensano, 1050 Brussels, Belgium.
European Program for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), 171 83 Stockholm, Sweden.

Bavo Verhaegen (B)

Infectious Diseases in Humans, Sciensano, 1050 Brussels, Belgium.

Catherine Linard (C)

ILEE, University of Namur, 5000 Namur, Belgium.
NARILIS, University of Namur, 5000 Namur, Belgium.

Lies Lahousse (L)

Department Bioanalysis, Ghent University, 9000 Ghent, Belgium.

Peter Delputte (P)

Laboratory for Microbiology, Parasitology and Hygiene, Antwerpen University, 2610 Wilrijk, Belgium.

Matthieu Terwagne (M)

E-BIOM SA, 5000 Namur, Belgium.

Jonathan Marescaux (J)

E-BIOM SA, 5000 Namur, Belgium.

Rosalie Pype (R)

Société Publique de Gestion de l'Eau, 4800 Verviers, Belgium.

Christian Didy (C)

Société Publique de Gestion de l'Eau, 4800 Verviers, Belgium.

Katelijne Dierick (K)

Infectious Diseases in Humans, Sciensano, 1050 Brussels, Belgium.

Koenraad Van Hoorde (K)

Infectious Diseases in Humans, Sciensano, 1050 Brussels, Belgium.

Marie Lesenfants (M)

Epidemiology of Infectious Diseases, Sciensano, 1050 Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH